135 related articles for article (PubMed ID: 29111950)
41. 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder.
Martinez PE; Rubinow DR; Nieman LK; Koziol DE; Morrow AL; Schiller CE; Cintron D; Thompson KD; Khine KK; Schmidt PJ
Neuropsychopharmacology; 2016 Mar; 41(4):1093-102. PubMed ID: 26272051
[TBL] [Abstract][Full Text] [Related]
42. [Efficient assessment of premenstrual symptoms - German translation of the shortened Premenstrual Assessment Form and its psychometric evaluation].
Blaser BL; Weymar M; Wendt J
Psychother Psychosom Med Psychol; 2023 Oct; 73(9-10):405-412. PubMed ID: 37619601
[TBL] [Abstract][Full Text] [Related]
43. Prevalence and factors associated with Premenstrual Dysphoric Disorder: A community sample of young adult women.
de Carvalho AB; Cardoso TA; Mondin TC; da Silva RA; Souza LDM; Magalhães PVDS; Jansen K
Psychiatry Res; 2018 Oct; 268():42-45. PubMed ID: 29986177
[TBL] [Abstract][Full Text] [Related]
44. The late-luteal leptin level, caloric intake and eating behaviors among women with premenstrual dysphoric disorder.
Ko CH; Yen CF; Long CY; Kuo YT; Chen CS; Yen JY
Psychoneuroendocrinology; 2015 Jun; 56():52-61. PubMed ID: 25800149
[TBL] [Abstract][Full Text] [Related]
45. [Development and validation of a questionnaire for patient competence in coping with cancer (PCQ)].
Aderhold C; Morawa E; Paslakis G; Erim Y
Z Psychosom Med Psychother; 2019 Sep; 65(3):239-256. PubMed ID: 31476991
[TBL] [Abstract][Full Text] [Related]
46. Premenstrual dysphoric disorder and eating disorders.
Verri A; Nappi RE; Vallero E; Galli C; Sances G; Martignoni E
Cephalalgia; 1997 Dec; 17 Suppl 20():25-8. PubMed ID: 9496774
[TBL] [Abstract][Full Text] [Related]
47. Vitex agnus castus for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review.
Cerqueira RO; Frey BN; Leclerc E; Brietzke E
Arch Womens Ment Health; 2017 Dec; 20(6):713-719. PubMed ID: 29063202
[TBL] [Abstract][Full Text] [Related]
48. [Current Aspects of Premenstrual Dysphoric Disorder - A Review].
Beddig T; Kühner C
Psychother Psychosom Med Psychol; 2017 Dec; 67(12):504-513. PubMed ID: 28778107
[TBL] [Abstract][Full Text] [Related]
49. Pre-menstrual Syndrome and Pre-menstrual Dysphoric Disorder in Female Medical Students of Nepal.
Mahat A; Dhungana R; Amatya A
Kathmandu Univ Med J (KUMJ); 2023; 21(81):46-51. PubMed ID: 37800425
[TBL] [Abstract][Full Text] [Related]
50. Prevalence and association of premenstrual syndrome and premenstrual dysphoric disorder with academic performance among female university students.
Hussein Shehadeh J; Hamdan-Mansour AM
Perspect Psychiatr Care; 2018 Apr; 54(2):176-184. PubMed ID: 28543046
[TBL] [Abstract][Full Text] [Related]
51. Premenstrual disorders and rumination.
Craner JR; Sigmon ST; Martinson AA; McGillicuddy ML
J Clin Psychol; 2014 Jan; 70(1):32-47. PubMed ID: 23798035
[TBL] [Abstract][Full Text] [Related]
52. Explorative evaluation of the impact of severe premenstrual disorders on work absenteeism and productivity.
Heinemann LA; Minh TD; Filonenko A; Uhl-Hochgräber K
Womens Health Issues; 2010; 20(1):58-65. PubMed ID: 20123176
[TBL] [Abstract][Full Text] [Related]
53. Validation of the Pain Coping Questionnaire in Finnish.
Marttinen MK; Santavirta N; Kauppi MJ; Pohjankoski H; Vuorimaa H
Eur J Pain; 2018 May; 22(5):1016-1025. PubMed ID: 29388281
[TBL] [Abstract][Full Text] [Related]
54. [Multidimensional assessment of coping: validation of the Brief COPE among French population].
Muller L; Spitz E
Encephale; 2003; 29(6):507-18. PubMed ID: 15029085
[TBL] [Abstract][Full Text] [Related]
55. Investigation of coping behaviors and premenstrual syndrome among university students.
Akın Ö; Erbil N
Curr Psychol; 2023 Feb; ():1-11. PubMed ID: 37359568
[TBL] [Abstract][Full Text] [Related]
56. Assessing self-management in patients with diabetes mellitus type 2 in Germany: validation of a German version of the Summary of Diabetes Self-Care Activities measure (SDSCA-G).
Kamradt M; Bozorgmehr K; Krisam J; Freund T; Kiel M; Qreini M; Flum E; Berger S; Besier W; Szecsenyi J; Ose D
Health Qual Life Outcomes; 2014 Dec; 12():185. PubMed ID: 25519204
[TBL] [Abstract][Full Text] [Related]
57. Self-focused attention in response to laboratory stressors among women with premenstrual disorders.
Craner JR; Sigmon ST; Martinson AA
Arch Womens Ment Health; 2015 Aug; 18(4):595-606. PubMed ID: 25647070
[TBL] [Abstract][Full Text] [Related]
58. Sexual satisfaction in females with premenstrual symptoms.
Nowosielski K; Drosdzol A; Skrzypulec V; Plinta R
J Sex Med; 2010 Nov; 7(11):3589-97. PubMed ID: 20646188
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder.
Freeman EW; Kroll R; Rapkin A; Pearlstein T; Brown C; Parsey K; Zhang P; Patel H; Foegh M;
J Womens Health Gend Based Med; 2001; 10(6):561-9. PubMed ID: 11559453
[TBL] [Abstract][Full Text] [Related]
60. Premenstrual symptom severity: impact on social functioning and treatment-seeking behaviors.
Robinson RL; Swindle RW
J Womens Health Gend Based Med; 2000 Sep; 9(7):757-68. PubMed ID: 11025868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
